Trial intelligence / Profile preview

Arasertaconazole nitrate dose-finding in VVC

NCT01144286Phase 2Completed

Sponsor
Ferrer
Start
Jun 2010
Primary completion
Mar 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Arasertaconazole nitrate in vulvovaginal candidiasis (VVC), sponsored by Ferrer. Started Jun 2010; status: completed.

02

Drugs

Arasertaconazole nitrate
03

Conditions

vulvovaginal candidiasis (VVC)

Beyond the preview

Go deeper on NCT01144286.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01144286.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call